Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Home
/
About the Reporter
/
Park Pyeongtak
Park Pyeongtak
Reporter
Biowatch Team
With a background in Business Administration (MBA), I focus on the pharmaceutical and biotech industries. My goal is to select key information and present it in an easily understandable manner.
mail
ppt@kormedi.com
Latest Articles
Dongkook Pharmaceutical Secures 39 Billion Won Latin American Export Deal for BPH Treatment Uresco
7/6/2026
Qurient’s Mocaciclib Opens New Combination Frontiers for Hard-to-Treat Breast Cancer
7/6/2026
Samsung Biologics Labor Dispute Set for Limited Q2 Impact, but Second-Half Outlook Hinges on Union Deal and U.S. Plant Costs
7/6/2026
Medytox’s Neuramis Clinches China Approval, Paving Way for Dermal Filler Market Entry
6/27/2026
Rznomics Secures U.S. Patent for Alzheimer’s RNA Therapy Candidate RZ-003
6/26/2026
AI Fills the Care Gap: VUNO’s DeepCARS Cuts In-Hospital Cardiac Arrests by 21% Without Rapid Response Teams
6/19/2026
SCL Healthcare Secures U.S. Patent for Genetic Test Predicting Metabolic Syndrome Risk
6/19/2026
GC Wellbeing’s Laennec Injection Clears Phase 3 Hurdle for IV Drip Use, Boosting Growth Prospects
6/18/2026
Previous
7
8
9
10
11
Next